Methyltransferase DNMT3B promotes colorectal cancer cell proliferation by inhibiting PLCG2
Acta Biochimica et Biophysica Sinica · 01.08.2024
DOI: 10.3724/abbs.2024117 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biochimica et Biophysica Sinica, online erschienen am 07.08.2024. Verfasst von Yong Ji und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Yangzhou School of Clinical Medicine of Dalian Medical University, Yangzhou 225001, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Cell Proliferation, DNA (Cytosine-5-)-Methyltransferases, DNA Methyltransferase 3B. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Aberrant DNA methylation patterns in the promoter region of PLCG2 are associated with dysregulated signaling pathways and cellular functions. Its role in colorectal cancer cells is still unknown. In this study, qRT-PCR is used to measure DNMT3B expression in colorectal cancer. Western blot analysis and immunohistochemistry are used to analyze DNMT3B and PLCG2 protein levels in colorectal tissues and cell lines. Cell Counting Kit-8 (CCK-8) and colony formation assays are used to assess the proliferation of colorectal cancer cells. Methylation-specific PCR (MSP) and bisulfite-sequencing PCR (BSP) are used to measure DNA methylation level. Our results show that DNMT3B is overexpressed in colorectal cells in the TCGA datasets according to Kaplan-Meier plots. DNMT3B is significantly overexpressed in tumor tissues compared to that in adjacent nontumor tissues. Western blot analysis results demonstrate high expression of DNMT3B in tumor tissues. Compared to normal colonic epithelial cells, colorectal cancer cell lines exhibit elevated level of PLCG2 methylation. Overexpression of PLCG2 effectively prevents the growth of colorectal cancer xenograft tumors in vivo. PLCG2 is identified as a key downstream regulatory protein of DNMT3B in colorectal cancer. DNMT3B inhibits PLCG2 transcription through methylation of the PLCG2 promoter region. DNMT3B controls colorectal cancer cell proliferation through PLCG2, which is useful for developing therapeutic approaches that target PLCG2 expression for the treatment of colorectal cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Yangzhou School of Clinical Medicine of Dalian Medical University, Yangzhou 225001, China.
- Jingjiang People's Hospital, Jingjiang 214500, China.
- General Surgery Institute of Yangzhou, Yangzhou University, Yangzhou 225001, China.
- Yangzhou Key Laboratory of Basic and Clinical Transformation of Digestive and Metabolic Diseases, Yangzhou 225001, China.
- Clinical Medical College, Yangzhou University, Yangzhou 225001, China.
- The Yangzhou Clinical Medical College of Xuzhou Medical University, Yangzhou 225001, China.
Zitieren
APA
Ji, Y., Wang, Y., Zou, J., Liu, G., Xia, M., Ren, J., & Wang, D. (2024). Methyltransferase DNMT3B promotes colorectal cancer cell proliferation by inhibiting PLCG2. Acta Biochimica et Biophysica Sinica. https://doi.org/10.3724/abbs.2024117
Vancouver
Ji Y, Wang Y, Zou J, Liu G, Xia M, Ren J, et al. Methyltransferase DNMT3B promotes colorectal cancer cell proliferation by inhibiting PLCG2. Acta Biochimica et Biophysica Sinica. 2024. doi:10.3724/abbs.2024117
BibTeX
@article{Ji2024,
author = {Ji, Yong and Wang, Yang and Zou, Jiacheng and Liu, Guanghao and Xia, Mingyu and Ren, Jun and Wang, Daorong},
title = {Methyltransferase DNMT3B promotes colorectal cancer cell proliferation by inhibiting PLCG2},
journal = {Acta Biochimica et Biophysica Sinica},
year = {2024},
doi = {10.3724/abbs.2024117}
}
EUVIMED